RFA
CATX icon

Reilly Financial Advisors’s Perspective Therapeutics CATX Stock Holding History

Reilly Financial Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-20
Closed – – 1307
2015
Q2 		$0 Buy
+20
New +$324 ﹤0.01% 1362

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Reilly Financial Advisors's CATX Position: Q3 2015 in Review

Reilly Financial Advisors sold out of Perspective Therapeutics (CATX) in Q3 2015, closing a stake of 20 shares.

Reilly Financial Advisors first reported a position in CATX in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 30 funds tracked by Wall St. Rank hold CATX as of Q3 2015.

  • Reilly Financial Advisors reported no remaining Perspective Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Reilly Financial Advisors sold 20 Perspective Therapeutics shares in Q3 2015.
  • Reilly Financial Advisors first reported a position in Perspective Therapeutics in Q2 2015 and held it in 1 quarter.
  • Reilly Financial Advisors's Perspective Therapeutics position peaked at $0 in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2015.

Based on Reilly Financial Advisors's 13F filing for Q3 2015, filed 21 Oct 2015.